APA (7th ed.) Citation

E, F., KP, G., GK, S., CP, E., AA, H., CE, P., . . . CJ, S. (2019). Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry. Prostate cancer and prostatic diseases, 22(3), 420. https://doi.org/10.1038/s41391-018-0121-2

Chicago Style (17th ed.) Citation

E, Francini, Gray KP, Shaw GK, Evan CP, Hamid AA, Perry CE, Kantoff PW, Taplin ME, and Sweeney CJ. "Impact of New Systemic Therapies on Overall Survival of Patients with Metastatic Castration-resistant Prostate Cancer in a Hospital-based Registry." Prostate Cancer and Prostatic Diseases 22, no. 3 (2019): 420. https://doi.org/10.1038/s41391-018-0121-2.

MLA (9th ed.) Citation

E, Francini, et al. "Impact of New Systemic Therapies on Overall Survival of Patients with Metastatic Castration-resistant Prostate Cancer in a Hospital-based Registry." Prostate Cancer and Prostatic Diseases, vol. 22, no. 3, 2019, p. 420, https://doi.org/10.1038/s41391-018-0121-2.